BIA 9-1067-302
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIA 9-1067-302, covering 2020-03-16 to 2020-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial [Phase 3]